The expression levels of CCL5 in the serum and tumor tissue of breast cancer patients were detected with a Luminex protein detection kit, and it was found that the expression of CCL5 in serum was positively correlated with the number of axillary lymph node metastases in breast cancer patients (Figure 2A). The gene discussed is CCL5; the disease is neoplasm.